Total:1,685    Page:38/113
First << 36 37 38 39 40 ... >> Last To Page Go  
Structure Name MW ACS No Drugbank_ID Formula Status
molecular structure Niflumic Acid 282.221 4394-00-7 DB04552 C13H8F3N2O2 FDA approved
molecular structure Netivudine 282.252 84558-93-0 C12H14N2O6
molecular structure Dimesna 282.382 16208-51-8, 45127-11-5 C4H8O6S4 Clinical trial - Phase III
molecular structure Anisotropine Methylbromide 282.448 80-50-2 DB00517 C17H32NO2 FDA approved
molecular structure Emepronium 282.451 27892-33-7 C20H28N
molecular structure Risedronate 283.113 105462-24-6 DB00884 C7H7NO7P2 FDA approved
molecular structure Oxtriphylline 283.332 4499-40-5, 13930-27-3, 146-71-4, 56553-57-2 DB01303 C7H8N4O2 FDA approved
molecular structure Sulfisoxazole 283.376 127-69-5 DB00263 C11H12N3O2S2 FDA approved
molecular structure Levallorphan 283.415 152-02-3 DB00504 C19H26NO FDA approved
molecular structure Tropicamide 284.359 1508-75-4 DB00809 C17H20N2O2 FDA approved
molecular structure Sulfaethidole 284.364 94-19-9, 1904-95-6 C10H12N4O2S2
molecular structure Promazine 284.427 58-40-2 DB00420 C17H21N2S FDA approved; US withdrawn
molecular structure Promethazine 284.427 60-87-7 DB01069 C17H21N2S FDA approved
molecular structure Lynestrenol 284.443 52-76-6 C20H28O
molecular structure Diazepam 284.746 439-14-5 DB00829 C16H13ClN2O FDA approved